ArticleScientific reports2025
LC-MS determination of Nicotiana benthamiana host plant proteins in the drug products of recombinant plant-produced pembrolizumab.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Polyphenol oxidase depletion in Nicotiana benthamiana enhances recombinant protein purification and preserves native protein integrity.The New phytologist · 2026Article
- First evidence for isolation and characterization of Bacopa monnieri (L.) Wettst-derived nanovesicles with anti-neuroblastoma potential.Scientific reports · 2026Article
- Development of anti-dengue virus D8 neutralizing monoclonal antibody production inBiotechnology reports (Amsterdam, Netherlands) · 2026Article
- Neuroprotective Effects of Huperzine B andAdvances in pharmacological and pharmaceutical sciences · 2026Article
- Acute anti-proliferative and anti-migratory effects of cannabidiol on C6 rat glioma, SH-SY5Y human neuroblastoma, and HT22 mouse hippocampal neuronal cell cultures.Frontiers in toxicology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Host proteins from Nicotiana benthamiana can remain in the recombinant biologic products after undergoing multiple steps of purification. These plant protein impurities may induce immunogenicity upon use. Therefore, controlling and monitoring host cell proteins is necessary throughout the process of recombinant protein production. Liquid chromatography-mass spectrometry (LC-MS) has been successfully used to characterize protein species down to nanogram levels in various types of samples. In this study, LC-MS was applied to detect N. benthamiana plant proteins in plant-produced pembrolizumab anti-cancer antibody. Two types of purification techniques, gravity flow with manually packed column and automated system with prepacked column, were studied. After purification, the protein products were primarily assessed with SDS-PAGE and Western blot analyses and further examined with LC-MS to confirm protein identity and investigate plant protein contaminations. The pembrolizumab sequence was confirmed with more than 89% coverage. A higher number of host plant proteins were detected in the protein samples purified with gravity flow column. Luminal-binding protein 5 and ribulose bisphosphate carboxylase (RuBisCO) enzyme were predominant host plant proteins detected. Luminal-binding protein 5 was observed in the products purified with both purification methods. It was likely bound to pembrolizumab antibody and co-eluted into eluate fraction as its sequence is similar to binding immunoglobulin protein (BiP). RuBisCO enzyme was detected in the samples purified with gravity flow only. Its presence was likely due to incomplete wash by gravity flow chromatography. In summary, this study provided an important clue for plant proteins that could be contaminated in plant-produced products and suggested that second column chromatography is required to enhance purification efficiency.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.